Fig. 4: Prevalence and genotype breakdown of ciprofloxacin and azithromycin resistant S. sonnei in three surveillance regions (Australia, England and USA) from 2016 to 2019. | Nature Communications

Fig. 4: Prevalence and genotype breakdown of ciprofloxacin and azithromycin resistant S. sonnei in three surveillance regions (Australia, England and USA) from 2016 to 2019.

From: Global population structure and genotyping framework for genomic surveillance of the major dysentery pathogen, Shigella sonnei

Fig. 4

In each plot, black lines indicate the proportion of genomes that are predicted resistant to (a) ciprofloxacin (defined as presence of ≥3 QRDR mutations) or (b) azithromycin (defined as carrying mph(A)). Error bars indicate 95% confidence intervals for the proportion resistant (n = 144–182 for Australia, n = 610–869 for England, n = 87–313 for USA). Stacked bars indicate the relative abundance of each genotype among resistant isolates, coloured by genotype as per legend.

Back to article page